title: These dermatological disorders share the features of being caused by hyperactivity of androgen within the pilosebaceous follicle, and although not life threatening are the source of a considerable psychological and emotional burden for patients. Foreword.
authors: Cherry Creek Dermatology, Denver, Colorado, USA.
authors: J Michael
authors: JM
authors: Maloney
mesh_terms: D000728:Androgens / Q000378:metabolism*; D002715:Chlormadinone Acetate / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D018859:Hair Follicle / Q000378:metabolism; D006801:Humans; D012871:Skin Diseases / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000728:Androgens; D003277:Contraceptives, Oral, Combined; C488302:ethinylestradiol-chlormadinone acetate; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol